Rhythmic Auditory Stimulation and Dual-task Gait Training in Chronic Stroke
11. juli 2026 opdateret af: Seda Karaca, Recep Tayyip Erdogan University
Combined Rhythmic Auditory Stimulation and Dual-task Gait Training in Individuals With Chronic Stroke: a Pre-post Study With Exploratory Age-stratified Analyses
Rhythmic auditory stimulation and dual-task gait training may improve post-stroke mobility, but evidence regarding integrated programmes and age-related differences in treatment response remains limited.
The aim of the study is to evaluate changes in mobility, balance, motor dual-task performance, concern about falling, and health-related quality of life after a six-week combined programme, and to explore whether responses differed across age strata.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This prospective single-group pre-post study included individuals with chronic stroke.
Participants completed supervised rhythmic auditory stimulation and progressively intensified motor dual-task gait training three times weekly for six weeks.
Outcomes included motor dual-task performance, Timed Up and Go, bilateral single-leg stance, Mini-BESTest, Falls Efficacy Scale-International, and SF-36.
An independent assessor, unaware of previous scores and age-stratum allocation, conducted baseline and post-intervention assessments.
Prespecified exploratory analyses compared changes across age strata.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
46
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Rize, Tyrkiet (Türkiye)
- Recep Tayyip Erdogan University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- age ≥45 years
- stroke ≥6 months previously
- ability to walk at least 10 m independently or with minimal assistance
- sufficient hearing to follow rhythmic auditory cues
Exclusion Criteria:
- advanced aphasia
- severe neglect, cognitive impairment,
- marked visual impairment,
- severe spasticity (Modified Ashworth Scale score15 ≥3)
- severe cardiopulmonary disease
- vestibular dysfunction
- an orthopaedic condition limiting walking
- progressive neurological disease
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Stroke Group
Participants completed a supervised six-week programme comprising three 30-minute sessions per week (18 sessions; planned dose, 540 minutes).
During each session, they synchronized their steps with a metronome while performing tandem walking with progressively demanding object-carrying tasks.
Participants maintained their usual walking speed and were instructed to give equal attention to gait and the concurrent motor task.
Progression was designed by the research team in accordance with general motor-learning principles and involved predefined weekly increases in metronome tempo and concurrent motor-task complexity.
|
The intervention combined RAS with progressively intensified motor dual-task gait training.6
Participants completed a supervised six-week programme comprising three 30-minute sessions per week (18 sessions; planned dose, 540 minutes).
During each session, they synchronized their steps with a metronome while performing tandem walking with progressively demanding object-carrying tasks.
Participants maintained their usual walking speed and were instructed to give equal attention to gait and the concurrent motor task.
Progression was designed by the research team in accordance with general motor-learning principles and involved predefined weekly increases in metronome tempo and concurrent motor-task complexity.
provided that the preceding stage had been completed safely.
All sessions were delivered individually by the same licensed physiotherapist experienced in neurology.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Motor dual-task performance
Tidsramme: at baseline and after the six-week programme
|
Participants completed a 10-m walk at their comfortable speed under single-task and motor dual-task conditions.
In the dual-task condition, they carried a ball while walking and were instructed to give equal attention to both tasks.
Three trials were performed under each condition, and mean completion time was used in the analysis.
Positive values indicated greater dual-task interference.
|
at baseline and after the six-week programme
|
|
Functional mobility
Tidsramme: at baseline and after the six-week programme
|
Functional mobility was assessed using the Timed Up and Go test, with shorter completion times indicating better performance.
One familiarization trial preceded the timed assessment.
|
at baseline and after the six-week programme
|
|
Balance
Tidsramme: at baseline and after the six-week programme
|
Dynamic balance was assessed using the 14-item Mini-BESTest, which evaluates anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait.
Total scores range from 0 to 28, with higher scores indicating better balance.
Static balance was assessed bilaterally using the Single-Leg Stance Test.
Two trials were performed on each side, and the longest duration before foot contact, stance-foot movement, or loss of balance was recorded.
|
at baseline and after the six-week programme
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
15. januar 2026
Primær færdiggørelse (Faktiske)
15. maj 2026
Studieafslutning (Faktiske)
15. maj 2026
Datoer for studieregistrering
Først indsendt
11. juli 2026
Først indsendt, der opfyldte QC-kriterier
11. juli 2026
Først opslået (Faktiske)
16. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
16. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2026/01-1781
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
I do not prefer.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .